Bone Biologics Corporation (BBLG) Net income 2016–2025
Bone Biologics Corporation (BBLG) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$3.1MFY2025 · since FY2016: -$25.9M → -$3.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.1M | +24.4% |
| FY2024 | -$4.1M | +54.0% |
| FY2023 | -$8.9M | -502.8% |
| FY2022 | -$1.5M | +7.8% |
| FY2021 | -$1.6M | +11.7% |
| FY2020 | -$1.8M | +46.7% |
| FY2019 | -$3.4M | +22.7% |
| FY2018 | -$4.4M | +37.2% |
| FY2017 | -$7.1M | +72.8% |
| FY2016 | -$25.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BBLG financial trends
BBLG RevenueBBLG Net marginBBLG Gross profitBBLG Gross marginBBLG Operating incomeBBLG Operating marginBBLG Operating cash flowBBLG Free cash flowBBLG Capital expendituresBBLG Return on equityBBLG Stock buybacksBBLG Dividends paidBBLG Total assetsBBLG Total liabilitiesBBLG Shareholders’ equityBBLG overview →